VarmX
VarmX is a drug development company, developing drugs to restore haemostasis in case of bleeding or emergency surgery in patients taking oral factor Xa inhibitors.
VMX-C001 may be a lifesaving antidote to oral factor Xa inhibitors which are widely used to prevent blood clotting, but which in some cases can cause excessive bleeding as a side-effect. VMX-C001 has been shown to restore haemostasis even in the presence of anticoagulation inhibitors and may potentially ameliorate excessive bleeding in emergencies or planned surgeries. The company is also investigating potential reversal agents for new factor XIa inhibitor candidates.
